[Initial clinical results from the use of a new antibiotic, Zimox, in dentistry and maxillofacial surgery].
Zimox (amoxicillin) has been experimented in a variety of stomatological inflammatory forms and in maxillo-facial surgery. Results with respect to the type of inflammation, pain response, impaired function oedema and trismus in various forms of dysodontiasis are reported.